| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |